Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
7.22
-0.26 (-3.48%)
At close: Oct 20, 2025, 4:00 PM EDT
7.25
+0.03 (0.42%)
After-hours: Oct 20, 2025, 4:00 PM EDT
Nutriband Revenue
Nutriband had revenue of $622.45K in the quarter ending July 31, 2025, with 40.56% growth. This brings the company's revenue in the last twelve months to $2.58M, up 42.92% year-over-year. In the fiscal year ending January 31, 2025, Nutriband had annual revenue of $2.14M with 2.60% growth.
Revenue (ttm)
$2.58M
Revenue Growth
+42.92%
P/S Ratio
32.32
Revenue / Employee
$198,312
Employees
13
Market Cap
86.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 2.14M | 54.22K | 2.60% |
Jan 31, 2024 | 2.09M | 5.71K | 0.27% |
Jan 31, 2023 | 2.08M | 657.46K | 46.23% |
Jan 31, 2022 | 1.42M | 478.45K | 50.70% |
Jan 31, 2021 | 943.70K | 573.06K | 154.61% |
Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NTRB News
- 10 days ago - Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch - GlobeNewsWire
- 12 days ago - Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology - GlobeNewsWire
- 12 days ago - Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference - GlobeNewsWire
- 26 days ago - Nutriband Inc. to Present at the MicroCap Rodeo Conference - GlobeNewsWire
- 5 weeks ago - Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl - GlobeNewsWire
- 6 weeks ago - Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 - GlobeNewsWire
- 2 months ago - Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025 - GlobeNewsWire
- 2 months ago - Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election - GlobeNewsWire